EOW Phase 0a refresh: Alnylam's earnings crash is single-name risk, not a lane story; the lane still holds capitulation and euphoria at once

Event

EOW Phase 0a refresh: Alnylam's earnings crash is single-name risk, not a lane story; the lane still holds capitulation and euphoria at once

Summary

  • Type: monitoring-check (subtype: qualitative continuity) - event_id: 2026-07-31-biotech-capital-cycle-eow-phase-0a-refresh - Source: (Sector Scorecard "Biotech Capital Cycle"; The Wild & Whacky — ALNY entry; Insight Wire — IQV filings/tape convergence). - Shift: Alnylam (not a key_ticker here but a lane-adjacent biotech name) fell sharply this week on i
4 events
DateTypeEvent
Jul 13 Desk NoteVertical: Biotech Capital Cycle — the theme is confirmed; the question is now entries Jun 4 Market SignalBiotech Funding Gate Jul 31 ScanBiotech Scan Jul 28 ScanBiotech Scan

No direct external sources are attached to this read.